Adaptation and Validation of Responsible Innovation Practices Scale for Innovativeness and Competitiveness of Pharmaceutical Companies in Pakistan

Abstract

The primary goal of this study was to examine the factor structure and psychometric properties of the adapted 5-Dimensional Responsible Innovation Practices Scale (5DRIPS) with identical measures and related outcomes, such as organizational innovativeness and competitiveness. This scale is designed to measure the responsible innovation practices of organizations aiming to achieve greater societal good in close consultation with the stakeholders. A group of academicians and industry experts established the face and content validity of the 5DRIPS. In a two-wave field survey, data were obtained from a randomized sample of 297 pharmaceutical managers approached conveniently. Results supported that 5DRIPS has excellent internal consistency, factor structure, and convergent, criterion, and discriminant validities. The scale significantly predicted organizational outcomes in terms of innovativeness and competitiveness. The mediation mechanism exhibited that all five dimensions of 5DRIPS significantly improved organizational innovativeness, which in turn enhanced organizational competitiveness. Implications of these findings are discussed. We suggest using 5DRIPS as a reliable and valid measure of responsible innovation practices in pharmaceutical organizations. It can also be applied in other small, medium, and large-scale manufacturing organizations.